Efficacy and safety of using topical cyclosporine A for treatment of moderate to severe dry eye disease
ConclusionsCyclosporine A ophthalmic emulsion 0.05% has been demonstrated to be effective and safe in human clinical trials. It reduces signs and symptoms of dry eye disease, with the fact that its effect continued to occur significantly within the treatment periods as well as improvement of ocular condition kept on, actually more slowly towards stability, despite the drug has already stopped.
Source: Saudi Journal of Ophthalmology - Category: Opthalmology Source Type: research
More News: Allergy | Clinical Trials | Cytology | Eyes | Middle East Health | Opthalmology | Restasis | Saudi Arabia Health | Sjogren's Syndrome | Study